GPI-1485
CAS No. 186268-78-0
GPI-1485( GM1485 )
Catalog No. M28922 CAS No. 186268-78-0
GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 147 | Get Quote |
|
| 10MG | 222 | Get Quote |
|
| 25MG | 410 | Get Quote |
|
| 50MG | 605 | Get Quote |
|
| 100MG | 860 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGPI-1485
-
NoteResearch use only, not for human use.
-
Brief DescriptionGPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.
-
DescriptionGPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.(In Vitro):GPI-1485 induced cellular reprogramming and neural cell induction in normal human dermal fibroblasts (NHDF) .(In Vivo):GPI-1485 (5 mg/kg; intraperitoneal injection; 6-week period of daily) improved long-term neurological recovery in rats
-
In VitroGPI-1485 (GM1485; 100 μM) induces cellular reprogramming and neural cell induction in normal human dermal fibroblasts (NHDF). Cell Viability Assay Cell Line:Normal human dermal fibroblasts (NHDF)Concentration:100 μM Incubation Time:Result:Induced cellular reprogramming and neural cell induction.
-
In VivoGPI-1485 (GM1485; 5 mg/kg; intraperitoneal injection; 6-week period of daily) improves long-term neurological recovery in rats. Animal Model:Adult male Wistar rats, weighing 250-300 g Dosage:5 mg/kg Administration:Intraperitoneal injection; daily; for a total of 42 days Result:Administration improved neurological function and is consistent with an upregulation of endogenous neurogenesis following stroke in rats.
-
SynonymsGM1485
-
PathwayOthers
-
TargetOther Targets
-
RecptorUSP8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186268-78-0
-
Formula Weight241.287
-
Molecular FormulaC12H19NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (414.46 mM)
-
SMILESCCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhiyu Li, et al. USP8 inhibitor and preparation method and application thereof. CN111138358A.
molnova catalog
related products
-
PF-04859989 HCl
PF-04859989 HCl is a brain-penetrable and irreversible inhibitor of kynurenine amino transferase II (KAT II), which is the enzyme responsible for most of the brain synthesis of kynurenic acid.
-
BI-6C9
BI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.
-
O-Acetyl-L-serine hy...
O-Acetylserine (OASS) is an acylated amino acid derivative. It is an intermediate in the biosynthesis of the common amino acid cysteine in bacteria and plants. Its presence in humans arises from either microbial metabolism in the gut or through consumption of foods containing OASS.
Cart
sales@molnova.com